Olani A, Galante D, Lakew M, Wakjira B, Mekonnen G, Rufael T
Pathogens. 2025; 14(1).
PMID: 39861000
PMC: 11768497.
DOI: 10.3390/pathogens14010039.
Pertea M, Luca S, Moraru D, Veliceasa B, Filip A, Grosu O
Microorganisms. 2024; 12(6).
PMID: 38930622
PMC: 11205670.
DOI: 10.3390/microorganisms12061240.
Matheson C, Robertson R
Harm Reduct J. 2022; 19(1):98.
PMID: 36038934
PMC: 9422131.
DOI: 10.1186/s12954-022-00680-y.
Norris M, Kirpich A, Bluhm A, Zincke D, Hadfield T, Ponciano J
PLoS Biol. 2020; 18(12):e3001052.
PMID: 33370274
PMC: 7793302.
DOI: 10.1371/journal.pbio.3001052.
Trayner K, Weir A, McAuley A, Godbole G, Amar C, Grant K
Harm Reduct J. 2018; 15(1):36.
PMID: 29996865
PMC: 6042261.
DOI: 10.1186/s12954-018-0243-9.
Anthrax: Where Margins are Merging between Emerging Threats and Bioterrorism.
Banerjee D, Chakraborty B, Chakraborty B
Indian J Dermatol. 2017; 62(5):456-458.
PMID: 28979006
PMC: 5618831.
DOI: 10.4103/ijd.IJD_378_17.
Alternative pre-approved and novel therapies for the treatment of anthrax.
Head B, Rubinstein E, Meyers A
BMC Infect Dis. 2016; 16(1):621.
PMID: 27809794
PMC: 5094018.
DOI: 10.1186/s12879-016-1951-y.
Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions.
Ciccarone D, Unick G, Cohen J, Mars S, Rosenblum D
Drug Alcohol Depend. 2016; 163:126-33.
PMID: 27155756
PMC: 4881875.
DOI: 10.1016/j.drugalcdep.2016.04.009.
The Ins and Outs of Anthrax Toxin.
Friebe S, van der Goot F, Burgi J
Toxins (Basel). 2016; 8(3).
PMID: 26978402
PMC: 4810214.
DOI: 10.3390/toxins8030069.
CD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal Factor.
Ascough S, Ingram R, Chu K, Musson J, Moore S, Gallagher T
Front Microbiol. 2016; 6:1506.
PMID: 26779161
PMC: 4700811.
DOI: 10.3389/fmicb.2015.01506.
Whole genome protein microarrays for serum profiling of immunodominant antigens of Bacillus anthracis.
Kempsell K, Kidd S, Lewandowski K, Elmore M, Charlton S, Yeates A
Front Microbiol. 2015; 6:747.
PMID: 26322022
PMC: 4534840.
DOI: 10.3389/fmicb.2015.00747.
Spatiotemporal Clustering Analysis and Risk Assessments of Human Cutaneous Anthrax in China, 2005-2012.
Zhang W, Wang L, Zhang X, Han Z, Hu W, Qian Q
PLoS One. 2015; 10(7):e0133736.
PMID: 26208355
PMC: 4514625.
DOI: 10.1371/journal.pone.0133736.
New insights into gastrointestinal anthrax infection.
Owen J, Yang T, Mohamadzadeh M
Trends Mol Med. 2015; 21(3):154-63.
PMID: 25577136
PMC: 4352373.
DOI: 10.1016/j.molmed.2014.12.003.
Armies of pestilence: CNS infections as potential weapons of mass destruction.
Hart B, Ketai L
AJNR Am J Neuroradiol. 2014; 36(6):1018-25.
PMID: 25477355
PMC: 8013034.
DOI: 10.3174/ajnr.A4177.
Lessons for control of heroin-associated anthrax in Europe from 2009-2010 outbreak case studies, London, UK.
Abbara A, Brooks T, Taylor G, Nolan M, Donaldson H, Manikon M
Emerg Infect Dis. 2014; 20(7):1115-22.
PMID: 24959910
PMC: 4073855.
DOI: 10.3201/eid2007.131764.
Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.
Ascough S, Ingram R, Chu K, Reynolds C, Musson J, Doganay M
PLoS Pathog. 2014; 10(5):e1004085.
PMID: 24788397
PMC: 4006929.
DOI: 10.1371/journal.ppat.1004085.
Two anthrax cases with soft tissue infection, severe oedema and sepsis in Danish heroin users.
Russell L, Pedersen M, Jensen A, Soes L, Hansen A
BMC Infect Dis. 2013; 13:408.
PMID: 24004900
PMC: 3844346.
DOI: 10.1186/1471-2334-13-408.
Infections with spore-forming bacteria in persons who inject drugs, 2000-2009.
Palmateer N, Hope V, Roy K, Marongiu A, White J, Grant K
Emerg Infect Dis. 2012; 19(1):29-34.
PMID: 23260795
PMC: 3557973.
DOI: 10.3201/eid1901.120044.
Molecular epidemiologic investigation of an anthrax outbreak among heroin users, Europe.
Price E, Seymour M, Sarovich D, Latham J, Wolken S, Mason J
Emerg Infect Dis. 2012; 18(8):1307-13.
PMID: 22840345
PMC: 3414016.
DOI: 10.3201/eid1808.111343.
An overview of anthrax infection including the recently identified form of disease in injection drug users.
Hicks C, Sweeney D, Cui X, Li Y, Eichacker P
Intensive Care Med. 2012; 38(7):1092-104.
PMID: 22527064
PMC: 3523299.
DOI: 10.1007/s00134-012-2541-0.